Allworth Financial LP Raises Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Allworth Financial LP increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 24.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 734 shares of the company’s stock after purchasing an additional 143 shares during the quarter. Allworth Financial LP’s holdings in HCA Healthcare were worth $234,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare during the third quarter worth about $39,000. Activest Wealth Management grew its position in shares of HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after purchasing an additional 125 shares in the last quarter. Canoe Financial LP purchased a new stake in shares of HCA Healthcare during the third quarter worth about $41,000. Capital Performance Advisors LLP bought a new position in HCA Healthcare during the third quarter valued at approximately $41,000. Finally, Pinnacle Bancorp Inc. boosted its stake in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Activity

In other news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Cantor Fitzgerald reissued an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a research note on Monday, January 27th. Morgan Stanley dropped their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Bank of America lowered their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 27th. Oppenheimer raised their price objective on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Finally, Royal Bank of Canada lowered their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Trading Down 1.7 %

Shares of NYSE HCA opened at $316.07 on Friday. The business’s 50 day moving average price is $313.53 and its 200-day moving average price is $350.83. The company has a market cap of $78.49 billion, a price-to-earnings ratio of 14.39, a PEG ratio of 1.10 and a beta of 1.64. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the company posted $5.90 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.91%. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.02%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.